AIGH Capital Management
Latest statistics and disclosures from AIGH Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SNDK, Zoom Video Communications In call, CSTL, PSNL, LASR, and represent 47.77% of AIGH Capital Management's stock portfolio.
- Added to shares of these 10 stocks: Zoom Video Communications In call (+$60M), VNDA (+$18M), KYTX (+$14M), ABEO (+$11M), Kempharm (+$9.0M), BKTI (+$8.4M), IDN (+$8.1M), FENC (+$6.9M), BYRN (+$6.6M), ARDX (+$5.5M).
- Started 9 new stock positions in ABEO, KYTX, QNRX, Zoom Video Communications In call, BYRN, Kempharm, APYX, VNDA, IDN.
- Reduced shares in these 10 stocks: Seagate Technology Hldngs Pl (-$3.4B), ZVRA (-$42M), , LUMN (-$16M), APPS (-$9.7M), , PSNL (-$7.9M), VELO (-$5.3M), PHAT (-$5.0M), .
- Sold out of its positions in GLW, APPS, ELVA, ZVRA, LUMN, MXL, MBLY, PHAT, VELO, VPG. VUZI, AMBA.
- AIGH Capital Management was a net seller of stock by $-3.4B.
- AIGH Capital Management has $412M in assets under management (AUM), dropping by 27.86%.
- Central Index Key (CIK): 0001835943
Tip: Access up to 7 years of quarterly data
Positions held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for AIGH Capital Management
AIGH Capital Management holds 34 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Sandisk Corp (SNDK) | 16.1 | $67M | 280k | 237.38 |
|
|
| Zoom Communications Call Call Option | 14.7 | $60M | NEW | 700k | 86.29 |
|
| Castle Biosciences (CSTL) | 5.9 | $24M | -11% | 625k | 38.90 |
|
| Personalis Ord (PSNL) | 5.6 | $23M | -25% | 2.9M | 7.96 |
|
| Nlight (LASR) | 5.5 | $23M | 600k | 37.51 |
|
|
| Day One Biopharmaceuticals I (DAWN) | 4.5 | $19M | +31% | 2.0M | 9.32 |
|
| Vanda Pharmaceuticals (VNDA) | 4.3 | $18M | NEW | 2.0M | 8.82 |
|
| Bk Technologies Corporation Com New (BKTI) | 3.8 | $16M | +113% | 212k | 74.59 |
|
| Domo Com Cl B (DOMO) | 3.8 | $16M | +36% | 1.8M | 8.43 |
|
| Esperion Therapeutics (ESPR) | 3.6 | $15M | +33% | 4.0M | 3.70 |
|
| Kyverna Therapeutics (KYTX) | 3.4 | $14M | NEW | 1.5M | 9.40 |
|
| Fennec Pharmaceuticals (FENC) | 3.0 | $12M | +132% | 1.6M | 7.70 |
|
| Lightpath Technologies Com Cl A (LPTH) | 2.7 | $11M | +14% | 1.0M | 10.80 |
|
| Abeona Therapeutics Com New (ABEO) | 2.6 | $11M | NEW | 2.0M | 5.27 |
|
| Zevra Therapeutics Call Call Option | 2.2 | $9.0M | NEW | 1.0M | 8.96 |
|
| Intellicheck Com New (IDN) | 2.0 | $8.1M | NEW | 1.2M | 6.68 |
|
| Larimar Therapeutics (LRMR) | 1.9 | $7.6M | +100% | 2.0M | 3.81 |
|
| Advanced Emissions (ARQ) | 1.8 | $7.4M | -11% | 2.3M | 3.27 |
|
| Ardelyx (ARDX) | 1.6 | $6.7M | +479% | 1.2M | 5.83 |
|
| Byrna Technologies Com New (BYRN) | 1.6 | $6.6M | NEW | 395k | 16.79 |
|
| Polypid (PYPD) | 1.4 | $5.8M | +26% | 1.3M | 4.34 |
|
| Coya Therapeutics Common Stock (COYA) | 1.4 | $5.7M | -11% | 975k | 5.80 |
|
| Seagate Technology Hldngs Call Call Option | 1.3 | $5.5M | -99% | 20k | 275.39 |
|
| Talphera Com New (TLPH) | 1.3 | $5.3M | +4% | 4.7M | 1.14 |
|
| Apyx Medical Corporation (APYX) | 0.9 | $3.9M | NEW | 1.1M | 3.50 |
|
| Acasti Pharma (GRCE) | 0.8 | $3.2M | 907k | 3.49 |
|
|
| Renovorx Com New (RNXT) | 0.6 | $2.4M | +8% | 2.8M | 0.84 |
|
| Elutia Cl A Com (ELUT) | 0.5 | $2.1M | -3% | 3.1M | 0.69 |
|
| Neuraxis (NRXS) | 0.4 | $1.8M | 400k | 4.54 |
|
|
| Ideal Pwr Com New (IPWR) | 0.4 | $1.5M | -4% | 492k | 3.09 |
|
| Smartkem Com New (SMTK) | 0.2 | $719k | +58% | 675k | 1.06 |
|
| Quoin Pharmaceuticals Sponsored Ads (QNRX) | 0.2 | $712k | NEW | 49k | 14.43 |
|
| Biofrontera Com New (BFRI) | 0.1 | $522k | -12% | 915k | 0.57 |
|
| Aprea Therapeutics Com New (APRE) | 0.1 | $316k | -31% | 371k | 0.85 |
|
Past Filings by AIGH Capital Management
SEC 13F filings are viewable for AIGH Capital Management going back to 2020
- AIGH Capital Management 2025 Q4 filed Feb. 2, 2026
- AIGH Capital Management 2025 Q3 filed Oct. 31, 2025
- AIGH Capital Management 2025 Q2 filed July 29, 2025
- AIGH Capital Management 2025 Q1 filed May 6, 2025
- AIGH Capital Management 2024 Q4 filed Feb. 12, 2025
- AIGH Capital Management 2024 Q3 filed Nov. 13, 2024
- AIGH Capital Management 2024 Q2 filed Aug. 7, 2024
- AIGH Capital Management 2024 Q1 filed May 14, 2024
- AIGH Capital Management 2023 Q4 filed Feb. 12, 2024
- AIGH Capital Management 2023 Q3 filed Nov. 13, 2023
- AIGH Capital Management 2023 Q2 filed Aug. 14, 2023
- AIGH Capital Management 2023 Q1 filed May 15, 2023
- AIGH Capital Management 2022 Q4 filed Feb. 15, 2023
- AIGH Capital Management 2022 Q3 filed Nov. 14, 2022
- AIGH Capital Management 2022 Q2 filed Aug. 12, 2022
- AIGH Capital Management 2022 Q1 filed May 12, 2022